Research ExplorerPublicationsPrevalence and disease burden of hyperhidrosis in the adult ...

Prevalence and disease burden of hyperhidrosis in the adult population

Standard

Prevalence and disease burden of hyperhidrosis in the adult population. / Augustin, M; Radtke, M A; Herberger, K; Kornek, T; Heigel, H; Schäfer, Ines.

In: DERMATOLOGY, Vol. 227, No. 1, 01.01.2013, p. 10-3.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Augustin, M, Radtke, MA, Herberger, K, Kornek, T, Heigel, H & Schäfer, I 2013, 'Prevalence and disease burden of hyperhidrosis in the adult population', DERMATOLOGY, vol. 227, no. 1, pp. 10-3. https://doi.org/10.1159/000351292

APA

Augustin, M., Radtke, M. A., Herberger, K., Kornek, T., Heigel, H., & Schäfer, I. (2013). Prevalence and disease burden of hyperhidrosis in the adult population. DERMATOLOGY, 227(1), 10-3. https://doi.org/10.1159/000351292

Vancouver

Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schäfer I. Prevalence and disease burden of hyperhidrosis in the adult population. DERMATOLOGY. 2013 Jan 1;227(1):10-3. https://doi.org/10.1159/000351292

Bibtex

@article{a65b21d3d4f345dab4b195efb9f77058,
title = "Prevalence and disease burden of hyperhidrosis in the adult population",
abstract = "BACKGROUND: Although hyperhidrosis is a common and burdensome condition, little is known about the population-based prevalence.OBJECTIVE: To evaluate the epidemiology, disease burden and medical care of hyperhidrosis in German adults.METHODS: Employees of fifty-two companies underwent skin screenings and interviews including hyperhidrosis questions.RESULTS: 14,336 individuals were investigated (36% women, mean age 42 years) of whom 2,340 (16.3%) reported hyperhidrosis, including 869 (6.1%) with frequent or continuous disturbing sweating. 28% showed focal hyperhidrosis, whilst 68% had a generalized condition. Predictors of hyperhidrosis were male gender and concomitant drug medication. Moreover, persons with psoriasis and with metabolic comorbidity were at increased risk. Only 27% of those with focal hyperhidrosis had consulted a physician, and only 28% used prescribed medication or self-medication.CONCLUSION: Hyperhidrosis is a frequent skin condition predicted by medical and personal factors. In spite of the disease burden, few individuals utilize medical care. Affected individuals should be encouraged to refer to a dermatologist.",
keywords = "Adolescent, Adult, Aged, Aluminum Compounds, Antihypertensive Agents, Astringents, Chlorides, Comorbidity, Cost of Illness, Cross-Sectional Studies, Female, Germany, Health Services, Humans, Hyperhidrosis, Male, Metabolic Diseases, Middle Aged, Onychomycosis, Prevalence, Psoriasis, Quality of Life, Sex Factors, Tinea Pedis, Young Adult",
author = "M Augustin and Radtke, {M A} and K Herberger and T Kornek and H Heigel and Ines Sch{\"a}fer",
year = "2013",
month = jan,
day = "1",
doi = "10.1159/000351292",
language = "English",
volume = "227",
pages = "10--3",
journal = "DERMATOLOGY",
issn = "1018-8665",
publisher = "S. Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - Prevalence and disease burden of hyperhidrosis in the adult population

AU - Augustin, M

AU - Radtke, M A

AU - Herberger, K

AU - Kornek, T

AU - Heigel, H

AU - Schäfer, Ines

PY - 2013/1/1

Y1 - 2013/1/1

N2 - BACKGROUND: Although hyperhidrosis is a common and burdensome condition, little is known about the population-based prevalence.OBJECTIVE: To evaluate the epidemiology, disease burden and medical care of hyperhidrosis in German adults.METHODS: Employees of fifty-two companies underwent skin screenings and interviews including hyperhidrosis questions.RESULTS: 14,336 individuals were investigated (36% women, mean age 42 years) of whom 2,340 (16.3%) reported hyperhidrosis, including 869 (6.1%) with frequent or continuous disturbing sweating. 28% showed focal hyperhidrosis, whilst 68% had a generalized condition. Predictors of hyperhidrosis were male gender and concomitant drug medication. Moreover, persons with psoriasis and with metabolic comorbidity were at increased risk. Only 27% of those with focal hyperhidrosis had consulted a physician, and only 28% used prescribed medication or self-medication.CONCLUSION: Hyperhidrosis is a frequent skin condition predicted by medical and personal factors. In spite of the disease burden, few individuals utilize medical care. Affected individuals should be encouraged to refer to a dermatologist.

AB - BACKGROUND: Although hyperhidrosis is a common and burdensome condition, little is known about the population-based prevalence.OBJECTIVE: To evaluate the epidemiology, disease burden and medical care of hyperhidrosis in German adults.METHODS: Employees of fifty-two companies underwent skin screenings and interviews including hyperhidrosis questions.RESULTS: 14,336 individuals were investigated (36% women, mean age 42 years) of whom 2,340 (16.3%) reported hyperhidrosis, including 869 (6.1%) with frequent or continuous disturbing sweating. 28% showed focal hyperhidrosis, whilst 68% had a generalized condition. Predictors of hyperhidrosis were male gender and concomitant drug medication. Moreover, persons with psoriasis and with metabolic comorbidity were at increased risk. Only 27% of those with focal hyperhidrosis had consulted a physician, and only 28% used prescribed medication or self-medication.CONCLUSION: Hyperhidrosis is a frequent skin condition predicted by medical and personal factors. In spite of the disease burden, few individuals utilize medical care. Affected individuals should be encouraged to refer to a dermatologist.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aluminum Compounds

KW - Antihypertensive Agents

KW - Astringents

KW - Chlorides

KW - Comorbidity

KW - Cost of Illness

KW - Cross-Sectional Studies

KW - Female

KW - Germany

KW - Health Services

KW - Humans

KW - Hyperhidrosis

KW - Male

KW - Metabolic Diseases

KW - Middle Aged

KW - Onychomycosis

KW - Prevalence

KW - Psoriasis

KW - Quality of Life

KW - Sex Factors

KW - Tinea Pedis

KW - Young Adult

U2 - 10.1159/000351292

DO - 10.1159/000351292

M3 - SCORING: Journal article

C2 - 23988406

VL - 227

SP - 10

EP - 13

JO - DERMATOLOGY

JF - DERMATOLOGY

SN - 1018-8665

IS - 1

ER -